FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1983864692> ?p ?o ?g. }

• W1983864692 endingPage "416" @default.
• W1983864692 startingPage "406" @default.
• W1983864692 abstract "Objective: To present an objective, evidence-based review of edema associated with thiazolidinedione use in patients with type 2 diabetes. Methods: We review the incidence, pathophysiology, and clinical significance of edema associated with the use of thiazolidinediones, with specific emphasis on the two currently available thiazolidinediones, rosiglitazone and pioglitazone. Results: Both pioglitazone and rosiglitazone have been associated with increased development of edema in clinical trials. The incidence of edema in these trials varies from about 3.0 to 7.5% with the thiazolidinediones compared with 1.0 to 2.5% with placebo or other oral antidiabetic therapy. The highest incidence of edema has been reported when thiazolidinediones are used in combination with insulin. In clinical studies, these patients have an incidence of edema of 15.3% when treated with insulin plus pioglitazone and 14.7% when treated with insulin plus rosiglitazone (compared with 7.0% and 5.4% in the insulin-only groups, respectively). In addition to peripheral edema, reports have described pulmonary edema associated with thiazolidinedione therapy. In all such reports, patients failed to respond to diuretics during use of thiazolidinediones. Clinical improvement ensued only after discontinuation of thiazolidinedione therapy. Therefore, thiazolidinediones either may have some effect on the delivery of diuretics to the lumen of the nephron or may induce tubular alterations that impair the ability of the nephrons to respond to diuretics. Several potential causes have been postulated to precipitate edema in patients with diabetes who are treated with these agents: increased plasma volume, increased renal sodium reabsorption, reflex sympathetic activation, alteration of intestinal ion transport, and increased production of vascular endothelial growth factor. Conclusion: Available evidence suggests that edema is a class effect of the thiazolidinediones and is multifactorial in origin. Thiazolidinedione-associated edema seems to be dose related and occurs most frequently when thiazolidinediones are used in combination with insulin. Hence, therapy with these agents should be initiated at low doses, and patients should undergo assessment for edema and congestive heart failure during the first few weeks of treatment. Caution should be exercised when thiazolidine- diones are used in those at risk for or with a history of heart failure. Options for management thiazolidinedione- associated edema include dose reduction, drug discontinuation, and symptomatic therapy with diuretics. Further studies are needed to elucidate the mechanisms responsible for the cause of edema in patients with type 2 diabetes treated with thiazolidinediones and to determine whether certain factors might predict susceptibility to development of edema and congestive heart failure. (Endocr Pract. 2003;9:406-416)" @default.
• W1983864692 created "2016-06-24" @default.
• W1983864692 creator A5013927934 @default.
• W1983864692 creator A5045462483 @default.
• W1983864692 creator A5089649262 @default.
• W1983864692 date "2003-10-01" @default.
• W1983864692 modified "2023-10-16" @default.
• W1983864692 title "Thiazolidinediones, Peripheral Edema, and Type 2 Diabetes: Incidence, Pathophysiology, and Clinical Implications" @default.
• W1983864692 cites W170520786 @default.
• W1983864692 cites W1964550567 @default.
• W1983864692 cites W1964716328 @default.
• W1983864692 cites W1980198526 @default.
• W1983864692 cites W1980270769 @default.
• W1983864692 cites W1984231396 @default.
• W1983864692 cites W2023323317 @default.
• W1983864692 cites W2023447984 @default.
• W1983864692 cites W2025284114 @default.
• W1983864692 cites W2028038659 @default.
• W1983864692 cites W2050736192 @default.
• W1983864692 cites W2053904622 @default.
• W1983864692 cites W2062560800 @default.
• W1983864692 cites W2062594120 @default.
• W1983864692 cites W2062819868 @default.
• W1983864692 cites W2113174062 @default.
• W1983864692 cites W2119615201 @default.
• W1983864692 cites W2124411103 @default.
• W1983864692 cites W2140603676 @default.
• W1983864692 cites W2157738006 @default.
• W1983864692 cites W2158030788 @default.
• W1983864692 cites W2159908382 @default.
• W1983864692 cites W2164471793 @default.
• W1983864692 cites W2169005776 @default.
• W1983864692 doi "https://doi.org/10.4158/ep.9.5.406" @default.
• W1983864692 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14583425" @default.
• W1983864692 hasPublicationYear "2003" @default.
• W1983864692 type Work @default.
• W1983864692 sameAs 1983864692 @default.
• W1983864692 citedByCount "175" @default.
• W1983864692 countsByYear W19838646922012 @default.
• W1983864692 countsByYear W19838646922013 @default.
• W1983864692 countsByYear W19838646922014 @default.
• W1983864692 countsByYear W19838646922015 @default.
• W1983864692 countsByYear W19838646922016 @default.
• W1983864692 countsByYear W19838646922017 @default.
• W1983864692 countsByYear W19838646922018 @default.
• W1983864692 countsByYear W19838646922019 @default.
• W1983864692 countsByYear W19838646922020 @default.
• W1983864692 countsByYear W19838646922021 @default.
• W1983864692 countsByYear W19838646922022 @default.
• W1983864692 countsByYear W19838646922023 @default.
• W1983864692 crossrefType "journal-article" @default.
• W1983864692 hasAuthorship W1983864692A5013927934 @default.
• W1983864692 hasAuthorship W1983864692A5045462483 @default.
• W1983864692 hasAuthorship W1983864692A5089649262 @default.
• W1983864692 hasConcept C126322002 @default.
• W1983864692 hasConcept C134018914 @default.
• W1983864692 hasConcept C197934379 @default.
• W1983864692 hasConcept C2776923340 @default.
• W1983864692 hasConcept C2777180221 @default.
• W1983864692 hasConcept C2777482430 @default.
• W1983864692 hasConcept C2778384471 @default.
• W1983864692 hasConcept C2779306644 @default.
• W1983864692 hasConcept C2780152017 @default.
• W1983864692 hasConcept C2780323712 @default.
• W1983864692 hasConcept C2780886150 @default.
• W1983864692 hasConcept C555293320 @default.
• W1983864692 hasConcept C71924100 @default.
• W1983864692 hasConceptScore W1983864692C126322002 @default.
• W1983864692 hasConceptScore W1983864692C134018914 @default.
• W1983864692 hasConceptScore W1983864692C197934379 @default.
• W1983864692 hasConceptScore W1983864692C2776923340 @default.
• W1983864692 hasConceptScore W1983864692C2777180221 @default.
• W1983864692 hasConceptScore W1983864692C2777482430 @default.
• W1983864692 hasConceptScore W1983864692C2778384471 @default.
• W1983864692 hasConceptScore W1983864692C2779306644 @default.
• W1983864692 hasConceptScore W1983864692C2780152017 @default.
• W1983864692 hasConceptScore W1983864692C2780323712 @default.
• W1983864692 hasConceptScore W1983864692C2780886150 @default.
• W1983864692 hasConceptScore W1983864692C555293320 @default.
• W1983864692 hasConceptScore W1983864692C71924100 @default.
• W1983864692 hasIssue "5" @default.
• W1983864692 hasLocation W19838646921 @default.
• W1983864692 hasOpenAccess W1983864692 @default.
• W1983864692 hasPrimaryLocation W19838646921 @default.
• W1983864692 hasRelatedWork W1551046670 @default.
• W1983864692 hasRelatedWork W1964594176 @default.
• W1983864692 hasRelatedWork W2020625666 @default.
• W1983864692 hasRelatedWork W2028316975 @default.
• W1983864692 hasRelatedWork W2045720668 @default.
• W1983864692 hasRelatedWork W2120086542 @default.
• W1983864692 hasRelatedWork W2172062051 @default.
• W1983864692 hasRelatedWork W2340355954 @default.
• W1983864692 hasRelatedWork W2354249222 @default.
• W1983864692 hasRelatedWork W3029800468 @default.
• W1983864692 hasVolume "9" @default.
• W1983864692 isParatext "false" @default.
• W1983864692 isRetracted "false" @default.
• W1983864692 magId "1983864692" @default.

• next